Table 4.
Baseline | 24h | 48h | 72h | ||
---|---|---|---|---|---|
Interleukin-6 (ng/dL) | Placebo | −0.6 ± 4.51 | −0.03 ± 6.22 | 4.88 ± 6.53 | 3.11 ± 4.26 |
Low | 0.75 ± 1.31 | 2.01 ± 2.44 | 0.35 ± 2.22 | 0.47 ± 5.61 | |
High | 0.44 ± 0.51 | 1.69 ± 1.75 | 1.34 ± 1.34 | −0.79 ± 5.34 | |
| |||||
Handgrip (kg) | Placebo | 33.4 ± 8.8 | 35.2 ± 8.7 | 35.3 ± 8.8 | 36.1 ± 8.4 |
Low | 32.2 ± 8.3 | 34.3 ± 11.1 | 33.6 ± 10 | 34.1 ± 9 | |
High | 34.7 ± 8.6 | 30.6 ± 8 | 34 ± 8.3 | 34.9 ± 9.9 | |
| |||||
Bicep Curl (kg) | Placebo | 26.4 ± 13 | 19.3 ± 15.8 | 23.6 ± 16.4 | 23.9 ± 14.5 |
Low | 24.8 ± 14.7 | 21.8 ± 16.8 | 25.3 ± 17.7 | 26.5 ± 16.7 | |
High | 29.1 ± 13.2 | 23.3 ± 15.9 | 24.7 ± 16.7 | 26.3 ± 17.1 | |
| |||||
Pain (a.u.) | Placebo | 0 ± 0 | 27.3 ± 14.9 | 23 ± 19.4 | 7.6 ± 7.4 |
Low | 0 ± 0 | 23.5 ± 22.3 | 8.5 ± 10.1 | 3.8 ± 4.5 | |
High | 0.3 ± 0.5 | 28 ± 25.6 | 13 ± 14.4 | 9.5 ± 9.1 | |
| |||||
Range of Motion (°) | Placebo | 171.5 ± 8.5 | 164.8 ± 10 | 166 ± 8.7 | 168.5 ± 8.3 |
Low | 176 ± 7 | 163.8 ± 13.5 | 166.3 ± 8.8 | 172 ± 2.9 | |
High | 174.3 ± 5 | 163.8 ± 8.5 | 164.5 ± 5.2 | 166.8 ± 2.4 |